Back

Prevalence and prognostic implication of left ventricular hypertrophy defined by different echocardiographic criteria

2 September 2024 (10:00 - 10:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment Epidemiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Anping Cai

Guangdong Provincial People's Hospital, Guangzhou (China)

3 More presentations in this session

Presentation thumbnail
Identification of premature cardiovascular disease using a family-based strategy: a feasibility pilot study
Mr P. Charleux (Paris, FR)
Abstract Slides Video
Presentation thumbnail
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study
Doctor E. Kaplan (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Predictors of cardiovascular disease risk: findings from the National Survey of Health and Development Cohort.
Doctor E. Agwara (Cambridge, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of left ventricular hypertrophy in patients with myocardial fibrosis by ECV mapping on cardiac MRI
thumbnail
Congress Presentation
Prognostic value of left ventricular phenotypes in patients with hypertensive heart disease using cardiac magnetic resonance
thumbnail
Congress Presentation
Evaluation of the combined value of three electrocardiographic criteria peguero-lo presti, sokolow-lyon and cornell in the diagnosis of left ventricular hypertension in patients with hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources